Becoming a NASH PASS® Clinical Trial Site for NAFLD and NASH

Originally recorded on October 1, 2020

NASH PASS is an IRB-approved clinical protocol that provides healthcare providers and clinical trial sites access to NASH expertise and imaging tools to identify and diagnose patients at-risk for fatty liver disease. The NASH PASS program also provides qualified principal investigators and diagnosed patients the opportunity to participate in clinical trials investigating new NAFLD and NASH drug candidates.

During this seven-minute webinar, the speakers will provide a brief introduction of the NASH PASS program from the perspective of becoming a NASH PASS clinical trial site.

Becoming a NASH PASS® Clinical Trial Site for NAFLD and NASH thumbnail

Recommended Materials

Becoming a NASH PASS® Clinical Trial Site for NAFLD and NASH thumbnail

Posters

NASH Patient Access and Screening Strategies or NASH PASS: An epidemiological, multicenter, prospective screening registry for adults with nonalcoholic steatohepatitis

Becoming a NASH PASS® Clinical Trial Site for NAFLD and NASH thumbnail

Posters

NASH PASS®: A Registry To Inform Study Design And Accelerate Patient Enrollment

Becoming a NASH PASS® Clinical Trial Site for NAFLD and NASH thumbnail

Webinars

Expediting NASH Clinical Trials and Biomarker Research: NASH PASS®, a Growing Clinical Research and Patient Registry Platform

Related Solutions

Overview thumbnail

Our Metabolic Focus

NASH (Nonalcoholic Steatohepatitis) thumbnail

NASH (Nonalcoholic Steatohepatitis)